To: Mama Bear who wrote (2461 ) 9/8/1998 7:47:00 PM From: RockyBalboa Respond to of 4634
Hi, Barb. I'm not talking fraud or other crying fire here but heres something to look at: HEB I watched the sharp runup of Hemispherx (AMEX:HEB). Most of the time, a $3 and under stock, it went over 12 in the meantime. Some issues are a bit disturbing, though. There are also some questions regarding insider activity, you probably know the mechanics of that. 1) HEB insiders filed some planned sales ahead of the run up. Is there any limitation on "Planned Sale" filing regarding limited time horizon ,ie. a planned sale must be consummated in a certain time period or it expires? Furthermore one insider "disposed" near 100k shares, whatever it means. I concede that recent insider activity is low, compared to the 21M outstanding shares.biz.yahoo.com 2) The co's numbers are not that sound, and the co. itself warns in their recent 10-k. Till now, the co has been in development stage neglectible revenues and a high demand to do financing as they consistently achieve negative cash flows. Financing history consists of a series of private placement, preferred stock, and warrant issues. Recently a preferred class E convertible preferred is outstanding but reading through the sec filing history did not bring to lights at which terms conversion may occur, the only S3 from feb 5 1998 registered an amount of shares which were enough to cover the preferred at a < $2 price. According to the recent 10-k, there are 3850 preferres shares still outstanding. The company is valued at a decent $240M market cap, with a $10m shareholder equity and some $6M cash, while burning 2M per quarter. Though, they state that they brought in $5M by issuing common stock to warrantholders after Jun 30 1998. In the past, warrant strikes have been around $3-4. 3) Company warns in "LIQUIDITY AND CAPITAL RESOURCES" ... "Because of the Company's long-term capital requirements, it may seek to access the public equity market whenever "conditions are favorable", even if it does not have an immediate need for additional capital at that time. Any additional funding may result in significant dilution and could involve the issuance of securities with rights which are senior to those of existing stockholders. The Company may also need additional funding earlier than anticipated, and the Company's cash requirements in general may vary materially from those now planned, for reasons including, but not limited to, changes in the Company's research and development programs, clinical trials, competitive and technological advances, the regulatory process, and higher than anticipated expenses and lower than anticipated revenues from certain of the Company's clinical trials for which cost recovery from participants as been approved." Comment: A rise from under 3 to 12 may indicate that "favorable conditions" (see first sentence) have been established? What do you think? Do you eventually know someone who has an opinion on HEB? Christian